GLINTARY has not observed an entity called “” in a public scan, research case or position. A famous name that has not been on the schedule is not here, and that is deliberate.
GLINTARY has not observed an entity called “” in a public scan, research case or position. A famous name that has not been on the schedule is not here, and that is deliberate.
Declined after researchCandidate · not a published position
Baseball · MLB · Starts
NOT AN OFFICIAL GLINTARY POSITION
This candidate was researched and did not become a published position. Nothing here was ever on the Board, in the Ledger or on X. Researched, assessed on merit and not published. Most candidates are meant to end here. The engine records this decision as PASS, which means the candidate passed through without a position.
Research history for this proposition
The same selection on the same fixture was researched more than once. Nothing is rewritten; the most recent record is the current view.
Best price too far above the market reference to be believed (and 2 more)
Gates that did not pass
PriceBest price too far above the market reference to be believedFailed
FreshnessPersonnel information older than the limitFailed
UncertaintyEvidence grade below the lockable setFailed
Full gate trace (9 gates)
Every gate in order, with its outcome and the reason code in words.
Event integrityReal, identified, pre-match fixture inside the lock windowPassed
EvidenceMaterial claims supported by enough distinct sourcesPassed
PriceBest price too far above the market reference to be believedFailed
Price sourcePrice attributable to an identified source (global reference only)Passed
FreshnessPersonnel information older than the limitFailed
UncertaintyEvidence grade below the lockable setFailed
Adversarial reviewAdversarial review raised no blocking objectionPassed
DuplicationNo conflicting positionPassed
PresentationPresentation compliantPassed
Research
Evidence grade B-Adversarial review · Medium
Texas Rangers at Seattle Mariners: Evaluation of Outlier Price Discrepancy
Evaluation of market pricing for Texas against Seattle on September 8, 2026, where outlier quotes of 2.300 (Winamax) and 2.380 (1xBet) exceed the consensus reference price of 2.140 across 49 operators, but face severe data freshness and confirmation deficits regarding starting pitching.
Primary case
The Texas Rangers (71-73) hold a superior overall record to the Seattle Mariners (67-77) across the 2026 season (source CS-6f9fa46c-5af).
Texas exhibits strong recent offensive metrics, recording 16 home runs, a.250 batting average, and a.446 slugging percentage over their last 10 games, alongside 4.05 runs per game overall (sources CS-c9cce9bf-33e, CS-2cacddbd-e3f).
Late-inning stability for Texas is supported by reliever Jacob Latz, who carries a 1.68 ERA and 26 saves on the season (source CS-2cacddbd-e3f).
Seattle faces key roster absences, with infielder Brendan Donovan on the 7-day injured list (concussion) and Luke Raley and Colt Emerson both sidelined on the 60-day injured list (claims CL-0081fd09-c27, CL-0f47f3fc-11e).
Major uncertainty
The starting pitching matchup (Bryce Miller vs. Cody Bradford) relies on a single Tier-3 source published over 44 hours ago (160,993 seconds), causing the personnel age of 48,573 seconds to severely exceed the maximum allowable threshold of 21,600 seconds and rendering the position non-lockable.
Market context
The market reference price sits at 2.140, derived as the median across 49 tracked operators, compared to a leave-one-out fair decimal price of 2.218.
Outlier quotes are present at 2.300 (winamax_de evaluation quote) and 2.380 (onexbet best global price).
Market dispersion across all 49 operators is 11.21 percent.
Price movement direction is unknown because only a single observation sample was captured with a null opening price.
What the price requires
Securing value at 2.300 or 2.380 requires that the broader consensus price of 2.140 undervalues Texas's true win probability rather than reflecting an accurate assessment of road risk and roster absences at T-Mobile Park.
Requires the probable starting pitching matchup of Cody Bradford against Bryce Miller to remain intact as projected without late scratch or rotation adjustments.
Material findings and their support14
Starting pitcher · material · for the caseBryce Miller is listed as the probable starting pitcher for the Seattle Mariners against the Rangers on September 8, 2026.Supported
Starting pitcher · material · for the caseCody Bradford is listed as the probable starting pitcher for the Texas Rangers against the Mariners on September 8, 2026.Supported
Injury · material · for the caseTexas Rangers third baseman Josh Jung is on the 10-day injured list with a calf injury.Supported
Injury · material · for the caseTexas Rangers catcher Kyle Higashioka is on the 10-day injured list due to a flexor tendon injury.Supported
Injury · for the caseRangers pitchers Cole Winn (shoulder) and Peyton Gray (elbow) are on the 15-day injured list, and Jalen Beeks (back) is on the 60-day injured list.Supported
Injury · material · for the caseSeattle Mariners infielder Brendan Donovan is on the 7-day injured list with a concussion/head injury.Supported
Injury · material · for the caseSeattle Mariners position players Luke Raley (forearm/elbow) and Colt Emerson (wrist tendon inflammation) are on the 60-day injured list.Supported
Injury · for the caseSeattle Mariners pitchers Emerson Hancock (adductor/groin) and Cole Wilcox (oblique) are on the 15-day injured list, while Matt Brash (lat) is on the 60-day injured list.
Adversarial review
The strongest case against the candidate, as recorded before the decision.
The starting pitching matchup (Bryce Miller vs. Cody Bradford) relies on a single Tier-3 source published over 44 hours ago (160,993 seconds), causing the personnel age of 48,573 seconds to severely exceed the maximum allowable threshold of 21,600 seconds and rendering the position non-lockable.
Blocking questions and why the market may be right
Why the market may simply be right
Consensus across 49 operators places the median price at 2.140, suggesting the broader market is pricing Texas win probability closer to ~45% before devig and that 2.300+ is an isolated outlier.
The market may be properly accounting for Texas's injury list absences (Jung, Higashioka) against Seattle at home.
Why it entered research
Deterministic screening facts recorded when the scan admitted this selection. No model was involved at this step.
The screening row for this candidate was not retained.
Market
Moneyline
Best verified price
2.380
Market reference
2.115 · 50 operators
Minimum Qualifying Odds
2.25 · edge 6.06%
Technical detailsCandidate and scan identifiers, policy version, raw timestamps.
Venue · for the caseThe game is scheduled to take place at T-Mobile Park in Seattle, Washington.Supported
Other · material · for the caseBryce Miller is scheduled to start for the Seattle Mariners against Cody Bradford for the Texas Rangers on September 8, 2026.Supported
Other · material · for the caseSeveral key players for both the Rangers and Mariners are sidelined on the injured list ahead of their September 8 meeting.Supported
Injury · against the caseRangers pitcher Nathan Eovaldi was placed on the 15-day injured list due to elbow inflammation.Stale
Injury · against the caseRangers reliever Jakob Junis was placed on the 15-day injured list with a left adductor strain.Stale
Other · against the caseTexas Rangers pitcher Nathan Eovaldi was placed on the 15-day injured list due to elbow inflammation.Stale
Seattle Mariners vs Texas Rangers: Texas Rangers to win researched 8 September 2026, Declined after research | GLINTARY
